These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11015698)

  • 21. Prevalence, prenatal screening and neonatal features in children with Down syndrome: a registry-based national study.
    Glivetic T; Rodin U; Milosevic M; Mayer D; Filipovic-Grcic B; Seferovic Saric M
    Ital J Pediatr; 2015 Oct; 41():81. PubMed ID: 26511759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal Down syndrome screening: a cost effectiveness analysis of alternative screening programs.
    Cusick W; Vintzileos AM
    J Matern Fetal Med; 1999; 8(6):243-8. PubMed ID: 10582856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Down syndrome in Glasgow, 1980-96--the growing impact of prenatal diagnosis on younger mothers.
    Iliyasu Z; Gilmour WH; Stone DH
    Health Bull (Edinb); 2002 Jan; 60(1):20-6. PubMed ID: 12664764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea.
    Park GW; Kim NE; Choi EK; Yang HJ; Won S; Lee YJ
    J Korean Med Sci; 2019 Aug; 34(31):e207. PubMed ID: 31392854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-year trends in prevalence of Down syndrome in a developing country: impact of the maternal age and prenatal screening.
    Kurtovic-Kozaric A; Mehinovic L; Malesevic R; Mesanovic S; Jaros T; Stomornjak-Vukadin M; Mackic-Djurovic M; Ibrulj S; Kurtovic-Basic I; Kozaric M
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():79-83. PubMed ID: 27639605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prenatal diagnosis of Down syndrome in Denmark 1980-1998 and future progress perspectives].
    Larsen SO; Hansen J; Christiansen M; Nørgaard-Pedersen B
    Ugeskr Laeger; 2002 Sep; 164(39):4532-6. PubMed ID: 12380396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Variations in the prevalence of Down's syndrome in the French population between 1978 and 2005].
    Rousseau T; Amar E; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
    J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):290-6. PubMed ID: 20430534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equipoise of recent estimated Down syndrome live births in Japan.
    Sasaki A; Sago H
    Am J Med Genet A; 2019 Sep; 179(9):1815-1819. PubMed ID: 31313514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International trends of Down syndrome 1993-2004: Births in relation to maternal age and terminations of pregnancies.
    Cocchi G; Gualdi S; Bower C; Halliday J; Jonsson B; Myrelid A; Mastroiacovo P; Amar E; Bakker MK; Correa A; Doray B; Melve KK; Koshnood B; Landau D; Mutchinick OM; Pierini A; Ritvanen A; Ruddock V; Scarano G; Sibbald B; Sípek A; Tenconi R; Tucker D; Annerén G
    Birth Defects Res A Clin Mol Teratol; 2010 Jun; 88(6):474-9. PubMed ID: 20589916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of prenatal diagnosis in Cuba: causes of low prevalence of Down syndrome.
    Méndez-Rosado LA; Hechavarría-Estenoz D; de la Torre ME; Pimentel-Benitez H; Hernández-Gil J; Perez B; Barrios-Martínez A; Morales-Rodriguez E; Soriano-Torres M; Garcia M; Suarez-Mayedo U; Cedeño-Aparicio N; Blanco I; Díaz-Véliz P; Vidal-Hernández B; Mitjans-Torres M; Miñoso S; Alvarez-Espinosa D; Reyes-Hernández E; Angulo-Cebada E; Torres-Palacios M; Lozano-Lezcano L; Lima-Rodriguez U; Mayeta M; Noblet M; Benítez Y; Lardoeyt-Ferrer R; Yosela-Martin S; Carbonell P; Pérez-Ramos M; de León N; Perez M; Carbonell J
    Prenat Diagn; 2014 Nov; 34(11):1049-54. PubMed ID: 24861354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of a Down syndrome live birth in women 45 years of age and older.
    Morris JK; De Vigan C; Mutton DE; Alberman E
    Prenat Diagn; 2005 Apr; 25(4):275-8. PubMed ID: 15849789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New insights into the support of children with Down syndrome].
    Weijerman M; Broers CJ; van der Plas RN
    Ned Tijdschr Geneeskd; 2013; 157(6):A5330. PubMed ID: 23388138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in medical technology and creation of disparities: the case of Down syndrome.
    Khoshnood B; De Vigan C; Vodovar V; Bréart G; Goffinet F; Blondel B
    Am J Public Health; 2006 Dec; 96(12):2139-44. PubMed ID: 17077393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Down syndrome in the northeastern Netherlands; expectations and reality 1981-1986].
    Cornel MC; Tuerlings JH; Breed AS; ten Kate LP
    Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1852-5. PubMed ID: 2145518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of prenatal diagnosis intervention for Down's syndrome in China.
    Chen Y; Qian X; Li J; Zhang J; Chu A; Schweitzer SO
    Int J Technol Assess Health Care; 2007; 23(1):138-45. PubMed ID: 17234028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study.
    Weijerman ME; van Furth AM; Vonk Noordegraaf A; van Wouwe JP; Broers CJ; Gemke RJ
    J Pediatr; 2008 Jan; 152(1):15-9. PubMed ID: 18154890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
    Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
    Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.